Cytotoxic and genotoxic effects of epoxiconazole on F98 glioma cells.


Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 30 11 2018
revised: 25 04 2019
accepted: 02 05 2019
pubmed: 13 5 2019
medline: 14 8 2019
entrez: 13 5 2019
Statut: ppublish

Résumé

Epoxiconazole (EPX) is a very effective fungicide of the triazole family. Given its wide spectrum of use, the increased application of this pesticide may represent a serious risk on human health. Previous studies have found that EPX is cytotoxic to cells, although the exact mechanism remains elusive. In particular, the effect on the nervous system is poorly elucidated. Here we evaluated the implication of oxidative stress in the neurotoxicity and studied its apoptotic mechanism of action. We demonstrated that the treatment by EPX reduces the viability of cells in a dose dependent manner with an IC50 of 50 μM. It also provokes the reduction of cell proliferation. EPX could trigger arrest in G1/S phase of cell cycle with low doses, however with IC50, it induced an accumulation of F98 cells in G2/M phase. Moreover, EPX induced cytoskeleton disruption as evidenced by immunocytochemical analysis. It provoked also DNA fragmentation in a concentration dependent manner. The EPX induced apoptosis, which was observed by morphological changes and by positive Annexin V FITC-PI staining concurrent with a depolarization of mitochondria. Furthermore, the cell mortality provoked by EPX was significantly reduced by pretreatment with Z-VAD-FMK, a caspase inhibitor. Moreover, N-acetylcysteine (NAC) strongly restores cell viability that has been inhibited by EPX. The results of these findings highlight the implication of ROS generation in the neurotoxicity induced by EPX, indicating that the production of ROS is the main cause of the induction of apoptosis probably via the mitochondrial pathway.

Identifiants

pubmed: 31078888
pii: S0045-6535(19)30914-2
doi: 10.1016/j.chemosphere.2019.05.018
pii:
doi:

Substances chimiques

Environmental Pollutants 0
Epoxy Compounds 0
Reactive Oxygen Species 0
Triazoles 0
epoxiconazole U80T84L776

Types de publication

Journal Article

Langues

eng

Pagination

314-323

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Hiba Hamdi (H)

Laboratory for Research on Biologically Compatible Compounds, Faculty of Dental Medicine, University of Monastir, Avicenne Street, Monastir, 5019, Tunisia; Higher Institute of Biotechnology, University of Monastir, Tunisia.

Salwa Abid-Essefi (S)

Laboratory for Research on Biologically Compatible Compounds, Faculty of Dental Medicine, University of Monastir, Avicenne Street, Monastir, 5019, Tunisia.

Joel Eyer (J)

Laboratoire Micro et Nanomédecines Translationnelles (MINT), Inserm 1066, CNRS 6021, Institut de Biologie de la Santé, Centre Hospitalier Universitaire, Angers, 49033, France. Electronic address: joel.eyer@univ-angers.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH